| scholarly article | Q13442814 |
| P2093 | author name string | Daniel H Fowler | |
| Seth M Steinberg | |||
| Michael R Bishop | |||
| Jeanne Odom | |||
| Ronald E Gress | |||
| Juan Gea-Banacloche | |||
| Jason Foley | |||
| Claude Kasten-Sportes | |||
| Jeannie Whit-Shan Hou | |||
| Kate Castro | |||
| P2860 | cites work | IL-1 is required for tumor invasiveness and angiogenesis | Q28594748 |
| Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH. | Q31510390 | ||
| Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia | Q33857573 | ||
| Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation | Q34086167 | ||
| Non-myeloablative stem cell transplants | Q34089106 | ||
| LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation | Q36028584 | ||
| The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice | Q36366817 | ||
| Fas ligand- mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease | Q37377818 | ||
| Graft-versus-host disease in experimental allogeneic bone marrow transplantation | Q37703665 | ||
| Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects | Q40706569 | ||
| Inflammatory reactions induced by pretransplant conditioning--an alternative target for modulation of acute GvHD and complications following allogeneic bone marrow transplantation? | Q40898694 | ||
| Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats | Q40933038 | ||
| Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease | Q41640832 | ||
| Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas | Q44372685 | ||
| Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. | Q44729936 | ||
| Measurement of serum cytokines | Q47741684 | ||
| A sharper Bonferroni procedure for multiple tests of significance | Q56622251 | ||
| PRETRANSPLANT CHEMOTHERAPY REDUCES INFLAMMATORY CYTOKINE PRODUCTION AND ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION | Q57252645 | ||
| Etanercept in graft-versus-host disease | Q60231893 | ||
| Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors | Q70051817 | ||
| Plasma cytokines in graft vs host disease and complications following bone marrow transplantation | Q73193864 | ||
| IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade | Q73497705 | ||
| Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease | Q73740251 | ||
| Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants | Q73942359 | ||
| Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation | Q74121701 | ||
| Acute graft-versus-host disease does not require alloantigen expression on host epithelium | Q74221421 | ||
| Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody | Q74350027 | ||
| Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation | Q77400039 | ||
| Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation | Q78410438 | ||
| Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation | Q78494858 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytokine storm | Q1076369 |
| flow cytometry | Q1141429 | ||
| P304 | page(s) | 237-245 | |
| P577 | publication date | 2004-03-01 | |
| P1433 | published in | Clinical Gastroenterology and Hepatology | Q5133759 |
| P1476 | title | Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease | |
| P478 | volume | 2 |
| Q52860217 | A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation. |
| Q36059671 | Acute graft versus host disease |
| Q36970235 | Acute graft-versus-host disease in children |
| Q35889876 | Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. |
| Q42181212 | CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers |
| Q36766430 | Chronic graft-versus-host disease in the era of reduced-intensity conditioning |
| Q35757981 | Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation |
| Q24187108 | Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients |
| Q24200282 | Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients |
| Q24200648 | Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients |
| Q40269737 | Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients |
| Q42200652 | Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation |
| Q40583092 | Immunonutrition Is Associated With a Decreased Incidence of Graft-Versus-Host Disease in Bone Marrow Transplant Recipients: A Meta-Analysis |
| Q36370782 | Implications of TNF-α in the pathogenesis and management of GVHD |
| Q45419646 | Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection. |
| Q37817036 | Prevention of GVHD without losing GVL effect: windows of opportunity |
| Q36402998 | TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease |
| Q33914006 | The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). |
| Q36253608 | Toll-like receptors in tumor immunotherapy |
| Q55386131 | Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology. |
Search more.